Planck Biomedical (Shenzhen) LTD
Planck is an innovative enterprise dedicated to near-infrared II (NIR-II) precision medical imaging technology. Addressing unmet clinical surgical needs, we build a platform for the R&D, translational development and commercialization of NIR-II imaging systems. Conventional near-infrared imaging suffers from limited penetration depth and high background noise. It cannot reliably discriminate diseased tissue from healthy parenchyma, raising risks of surgical complications. The demand for precise intraoperative navigation is especially urgent in oncological procedures. Powered by transformative NIR-II technology, Planck delivers “infrared super-vision” for surgeons, enabling clear visualization of deep tissues to achieve safer and more accurate surgery, safeguarding patient wellbeing through technology.
Our Core Strength: Disruptive Technology & Robust Innovation
Built on the research foundation of internationally recognized professors in NIR-II fluorescence imaging, the company has established a full-spectrum technical ecosystem spanning instrument development through clinical translation, with flagship products and innovation advantages at the industry forefront. Our product portfolio centers on NIR-II precision imaging. We will initially launch an open surgical imager, with endoscopic imagers on our long-term roadmap. Leveraging our proprietary core technology, our imaging performance substantially outperforms conventional modalities.
Our Outlook: A Blue-Ocean Market Worth Hundreds of Billions, Empowering Industry and Urban Growth
Our NIR-II imaging system targets high-value clinical workflows including precision tumor resection, ureter localization and visualization, and sentinel lymph node biopsy, representing substantial market potential. The initial clinical focus is urologic cancers, with future expansion into multi-disciplinary indications such as ovarian, breast, and head-and-neck cancers.
NIR-II Open-system Imaging Device
